Clinical trial
Kisspeptin in the Evaluation of Delayed Puberty
NCT01438034 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Kisspeptin in the Evaluation of Delayed Puberty
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- June 8, 2013
- Completion date
- September 10, 2021
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
delayed puberty, gnrh deficiency, hypogonadotropic hypogonadism, kallmann syndrome